6094 POSTER Impact of Early Tumour Shrinkage on Long-term Outcome in Metastatic Colorectal Cancer (mCRC) Treated With 5FU+lrinotecan+Leucovorin (FOLFIRI) or Capecitabine+lrinotecan XELIRI Plus Bevacizumab

Authors :: E. Francois
Antoine Adenis
M. Ducreux
J.L. Ichante
J-Y Pierga
Eveline Boucher
T. Conroy
J.R. Pignon
C. Montotot-Grillo
M. Ychou
Source :: European Journal of Cancer. 47:S419
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
XELIRI
Bevacizumab
business.industry
Colorectal cancer
medicine.disease
Capecitabine
Internal medicine
medicine
FOLFIRI
business
medicine.drug

Tools